ALOX15 and colorectal carcinoma: Furthermore, ALOX15 has been described as a tumour suppressor in CRC [18] and specific SPMs (i.e. RvD1, LXA4) have been demonstrated to exert antitumour activity in CRC models [19, 20, 21, 22, 23, 24].